Drug Brand Ranking

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. is a listed company controlled by Guangzhou Pharmaceutical Group Co., Ltd. (A shares 600332, H shares 00874), mainly engaged in: (1) Chinese and Western patent medicines, chemical raw materials, natural medicines, biomedicine, and chemical raw materials. Research, development, manufacturing and sales of intermediates; (2) Wholesale, retail and import and export business of Western medicine, Chinese medicine and medical devices; (3) R&D, production and sales of big health products; and (4) Medical services and health management , health industry investments such as health preservation and elderly care. The main traditional Chinese medicine products include Xiaoxie Pills, Qingkailing Series, Xiasangju Granules Series, Huatuo Rezai Pills, Angong Niuhuang Pills, Wanglaoji Herbal Tea, Wanglaoji Children's Qixing Tea, Zhuifeng Tougu Pills, etc.; the main chemical products include cefosthamidine , cefixime, amoxicillin, sildenafil citrate, etc.; the main health products include Wanglaoji herbal tea, Ganoderma lucidum spore oil soft capsules, etc.

NANYANG CHENGPENG PHARMACEUTICAL CO.,LTD

Nanyang Chengpeng Pharmaceutical was established in 2015 (formerly known as Henan Chengpeng Pharmaceutical Co., LTD.), is a collection of veterinary raw materials, veterinary premix APIs, veterinary soluble powder, feed additives, food additives, feed plant extracts and veterinary Chinese medicine extracts research and development and sales of export enterprises. In the highly competitive veterinary drug market, Chengpeng constantly tap its own potential, efficient and fast to undertake upstream and downstream customers, through years of unremitting efforts, the annual sales has exceeded 100 million, own domestic key veterinary drug cooperation factories, and has a more perfect marketing network. The company is fully qualified and has a veterinary drug business license. Professional casting quality, technology to create value! Chengpeng adheres to innovation and development, adheres to symbiosis and win-win, and is committed to build a better China animal husbandry pharmaceutical industry with animals healthier and food safer

Yunnan Baiyao Group Co., Ltd.

Yunnan Baiyao was created in 1902, combining brand, product and company name, and is a representative of the innovative power of Chinese time-honored brands. Yunnan Baiyao Special Factory was established in 1970, listed in 1993, and re-engineered modern enterprises in 1999. Migrant reform and overall listing were completed from 2016 to 2019, laying a solid institutional and mechanism foundation for the company to create another century of glory. The company is committed to bringing traditional Chinese medicine into modern life, and has developed from a bottle of powder to one of the leaders in my country's big health industry covering four major sectors: medicines, personal care and health products, Chinese medicinal materials resources and medical flow. The products have 36 categories and 390 varieties, and 11 products have sold hundreds of millions of dollars in a single product. Toothpaste, aerosol, bandages, paste patches, etc. are the top products in the country in related categories. The company adopts the business unit system to develop existing businesses, which are divided into medicines, health products, traditional Chinese medicine resources business departments and Yunnan Pharmaceutical Co., Ltd. (responsible for pharmaceutical abortion business). Each business department takes responsibility and works together, and its main business has reached the national advanced level. Deploy factories in Kunming, Dali, Wenshan, Lijiang, Wuding, Wuxi, Jiangsu, Hefei, Anhui, etc., with sales channels covering the whole country. The company regards protecting life and health as its corporate mission and is committed to becoming a leading provider of comprehensive medical and health solutions. Based on the above mission and vision, Yunnan Baiyao, on the basis of consolidating its existing business, determined the strategic goal of achieving "1+4+1" (Traditional medicine + oral, skin, bone injuries, female care + digitalization), and optimized the industry and R&D. The system has completed its layout in Beijing, Shanghai, Hong Kong, Hainan and South Korea, becoming an important strategic support for Baiyao to gather global resources and serve the Chinese market, and conducts basic research, commercial development, product innovation and marketing. The company carries out the "six major innovations" methods such as technological innovation, business model innovation, product innovation, organizational innovation, talent innovation and brand renewal, adopts the "four-wheel drive" model of marketing, innovation, capital and digitalization, and strives to achieve significant growth as soon as possible. and breakthroughs, and contribute to the leap in the development of China's pharmaceutical and health industry.

Shaanxi Changsheng Industrial Co., Ltd.

Over 21 years of professional experience Founded in December 2016, Shaanxi Changsheng Industrial Co., LTD is located in Xi'an City. The company consists of marketing department, R&D department and production department, and the R&D center has a technical team specialized in R&D with advanced testing, experimental and inspection equipment. The company has established good cooperation with many national scientific research institutions and universities, and has profound technical strength. The production workshop has several flat raw material production lines, as well as dynamic counter-current extraction column separation technology, membrane separation technology, high-efficiency counter-current extraction and microwave drying technology, with complete product specifications and stable quality. Main products We focus on Fruit & Vegetable powder, food additives, Cosmetic Raw Material,Herbal extract,Nutritional Supplements, men's health and other plant extracts and supply to all over the world. Quality Control System The quality control department has complete sets of advanced testing and experimental instruments such as gas, liquid and UV, and a detailed division of labor for technical research, quality assurance and quality testing, which allows for effective and comprehensive quality control of the production process and comprehensive inspection and analysis of the final product to ensure product quality. Export to more than 60 countries Our products have been sold all over the world, such as Japan, Korea, Middle East, Central Asia, Europe, Africa, India and South America, and we maintain cooperative relationships with more than 60 countries. We are firmly committed to the mission of creating a global trade network in supply, sales and service.   With excellent quality, reasonable prices, timely delivery capability and quality of service, we are able to meet your various needs and requirements. Contact us today to discuss mutually beneficial cooperation.      

Beijing Yushengtang Investment Group Co., Ltd.

Beijing Yushengtang Health Industry Group is formed by more than 20 companies that span the upstream and downstream industries of traditional Chinese medicine and accommodate various fields of traditional Chinese medicine. The group has always adhered to the mission of "promoting traditional Chinese medicine culture and revitalizing the traditional Chinese medicine industry" and is determined not to Moving on a unique path of development of traditional Chinese medicine enterprises, Yushengdo Group has grown into a brilliant star in the field of traditional Chinese medicine. The group aims to build an integrated operation platform for the entire industrial chain of traditional Chinese medicine and health, and has completed the overall strategic layout of seven major sections. Right now: 1. Medicinal Materials Section: With Beijing Yushengtang Bencao Technology Company as the core, it will set up a national planting, breeding and processing base to establish a large-scale, standardized, intensive and branded modern planting and breeding development model, taking into account high-quality The refining and environmental protection of Chinese medicinal materials, refining and selling Chinese medicinal decoctions will have good economic and ecological benefits to the development of enterprises and local areas. 2. R&D section: With Beijing Yushengtang Traditional Chinese Medicine Research Institute as the core, closely follow the world's theoretical innovation and technological innovation of traditional Chinese medicine, accelerate the absorption of modern traditional Chinese medicine science and technology and equipment, absorb senior talents in traditional Chinese medicine research and development, and accelerate the gathering of high-quality resources. Focus on building an advanced domestic traditional Chinese medicine innovation and research and development platform. After the platform is completed, in line with the corporate spirit of people-oriented and gratitude and dedication, our R&D center strives to achieve technology sharing, platform sharing and service sharing. 3. Pharmaceutical Section: With Beijing Yushengtang Pharmaceutical Co., Ltd. as the core, it has strategic layout (mergers, restructuring, integration) across the country, sharing resources, complementing each other's advantages, promoting high-quality development with the new development concept, and independent Innovate and enhance core competitiveness and produce and sell Chinese patent medicines. 4. Health Products Section: With Beijing Yushengtang Health Food Co., Ltd. as the core, it has developed and created a variety of health product sections, involving food, health food, diet therapy products, healthy beverages, health supplies, cosmetics, etc., and truly made We can use the best quality products, carefully crafted, and excellent quality, integrating excellent quality into every product, so that everyone can use it with confidence and affordable use. 5. Commercial section: With Beijing Yushengtang Marketing Management Co., Ltd. as the core, a complete online and offline product marketing network is laid nationwide to build a compound marketing channel composed of subsidiaries, pharmacy chains, specialty stores, online stores, etc. Keep up with the rapidly developing business waves of mobile Internet, big data, new media and other eras, embrace Internet+, quickly chase and lead the business direction of traditional Chinese medicine and health products, and expand Yushengtang's business territory. 6. Medical section: With Beijing Yushengtang Medical Technology Co., Ltd. as the core, it will carry out chain operation management and technical services for traditional Chinese medicine hospitals and specialty clinics in traditional Chinese medicine. 7. Health care section: With Beijing Yushengtang Health Management Co., Ltd. as the core, it will deploy the operation and construction of health care bases, health care service centers, and health care centers across the country, create a community operation service network, and spread the advanced concept of traditional Chinese medicine health management , provide residents with multi-faceted health services and promote Chinese traditional Chinese medicine culture.

Xi'an Day Natural Inc.

The company was founded in 2009, located in Xi 'an High-tech Zone, Shaanxi Province, the factory is located in Weinan city, Shaanxi province, covering an area of 100 mu. corporation. The main production of pure natural plant extracts, natural food pigments and cosmetics whitening additives. Has received national and international certifications, such as MUI HALAL certification, KOSHER certification, FDA, vegetarian certification, etc. The company's third party testing subsidiary, in collaboration with the global 500 Mérieux Group, is Mérieux NutriSciences. In the central laboratory of Northwest China, in the economic development zone, we have built professional third-party laboratories with fermentation products, traditional Chinese medicine and illegal additives as business characteristics, serving the development of the industry, and are committed to building a leading bench marking laboratory in Northwest China. Today, there is increasing concern about food safety and health issues, especially in the nutritional supplement industry. There is support for increased food safety protocols, verification of label claims, and transparency in the manufacture of raw materials and finished products. This requires that every enterprise must strictly control product quality to meet the standards of national laws and regulations. This adds to the difficulty for some companies, because not all companies have their own quality control inspection department. You need a large enough and technologically advanced laboratory to meet your needs, and DAYQC is the most professional quality control and inspection service provider around you. Our sourcing services, combined with the expertise of our third-party joint venture laboratories, help our customers ensure that their raw materials and finished products meet all ingredient purity and standards, helping them to manage risks at source. We have the power of large laboratory testing, but at the same time flexible and small enough, like your own in-house laboratory, can communicate at any time to provide a variety of customized testing services.

Xiuzheng Pharmaceutical Group Co., Ltd.

Xiuzheng Group was founded by Chairman Xiu Laigui in May 1995. It is a large modern private pharmaceutical enterprise integrating scientific research, production and marketing of patent medicines, chemical medicines, and biopharmaceuticals, pharmaceutical chain operations, and standard cultivation of traditional Chinese medicinal materials. Through secondary development, the group has cultivated more than a dozen major varieties such as Feining, Empty Hydrochloride, Liuwei Dihuang, Neiyaku Kang, Yiqi and Blood Health, etc.; it has integrated the transformation of scientific and technological management, innovative drug research, and new technological achievements into a domestic one. The scientific research system has more than 300 technical experts, more than 700 authorized patents, and won 7 national scientific and technological progress awards. There are nationally certified enterprise technology centers, national engineering laboratories for quality control technology in traditional Chinese medicine, postdoctoral research workstations, and key laboratories for key engineering technology in traditional Chinese medicine standardization. Correcting health is an important support for the big health strategy and an important wing for the revision of the "professional development, two wings flying together" strategy. Starting from 2021, we will focus on health product research and development and health management. Headquarters are located in Changchun, Jilin and Hangzhou, Zhejiang, respectively, including 8 industrial bases, covering an area of ​​more than 1,000 mu. Currently, six industrial bases in Changchun Shuangyang, Jilin Panshi, Baishan Jingyu, Shandong Weifang, Anhui Bozhou and Hangzhou Qiandaohu have been put into production. , sales channels cover multiple channels such as e-commerce, new retail, maternal and infant, pharmacies and supermarket third terminals. Currently, there are about 670 varieties in production and sales, 404 registered trademarks, and 50 patents. Its well-known products such as Spot Cream, Red Bean and Barley Tea, Xiuyisheng Probiotics, Uer Capsules, Svino Oral Liquid, Glycosammonia Chondroitin, and Youzhi DHA are well-known throughout the country, occupying the leading position in the big health sector and are deeply influenced by Good reviews from consumers. The product line covers a variety of dosage forms such as health foods, nourishing foods, fast-selling foods, alternative teas, health wines, mineral water, functional cosmetics, cosmetics, etc.

Huarun Jiangzhong Pharmaceutical Group Co., Ltd.

Jiangzhong Pharmaceutical Co., Ltd. (referred to as "Jiangzhong Pharmaceutical" or "Company") achieved backdoor listing through reorganization of Jiangxi Dongfeng Pharmaceutical Co., Ltd. in 1999. The stock abbreviation is Jiangzhong Pharmaceutical, with the stock code 600750. The company takes the traditional Chinese medicine industry as the core, combines traditional Chinese medicine theory with modern scientific research and technology platforms, and is mainly engaged in the research, development, production and sales of Chinese patent medicines and health foods, including "Jiangzhong", "Chuyuan" and "Yang Jisheng". , "Sanghai" and other trademarks, brand products include Jiangzhong Brand Jianweixiaoshi Tablets, Jiangzhong Brand Compound Grass Coral Lozenges, Lihuo Brand Lactobacillin Tablets, Chuyuan Brand Compound Amino Acid Oral Liquid, Shenling Grass Oral Liquid, Bo Locke, compound fresh bamboo juice liquid, Paishi Granules Sanghai Jinwei, Bazhen Yimu Capsules, etc. After years of development, the company has formed its own core expertise and capabilities in scientific research, production, marketing, etc. In terms of R&D, the R&D strength will be improved by relying on the "National Engineering Research Center for Solid Preparation Manufacturing Technology of Traditional Chinese Medicine", "Jiangzhong Pharmaceutical Base, Key Laboratory of Aerospace Nutrition and Food Engineering" and other engineering research centers and key laboratories; in terms of production, the company was the state in 2019 The Ministry of Ecology and Environment has rated it as the "China Ecological Civilization Award Advanced Collective".

Abbott Trading (Shanghai) Co., Ltd.

In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.

Lepu Medical Technology (Beijing) Co., Ltd.

Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as "Lepu Medical") was founded in 1999 and is one of the earliest enterprises in my country to engage in the research and development and manufacturing of cardiac interventional medical devices. For more than 20 years, the company has always focused on serving cardiovascular patients and drives high-quality development with innovation. It has now become the leading cardiovascular health industry platform in China. Its main business covers three major medical devices, drugs, medical services and health management. The sector was awarded the "National Research Center for the Engineering and Technology of Heart Disease Instrument and Instrument Engineering and Technology" by the Ministry of Science and Technology. The company's independently developed products such as bioabsorbable stents, cutting balloons, drug balloons, biodegradable occlusion devices, TAVR valves, artificial intelligence electrocardiocardiogram automatic analysis and diagnosis systems have reached the international leading level. In the future, Lepu Medical will continue to uphold the original intention of "serving cardiovascular patients wholeheartedly", and continue to provide full-life cycle services for disease prevention, diagnosis, drug treatment, surgical treatment, postoperative rehabilitation chronic disease management and re-prevention. On the basis of this, we will continue to increase technological innovation and actively deploy strategic emerging industries such as AI and medical care. While we are committed to providing advanced and high-quality products and services to the majority of patients, we will continue to promote industry technological progress and industrial improvement.

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson Medical Technology’s global history can be traced back to the beginning of Johnson & Johnson’s establishment in the United States in 1886. As one of the healthcare companies with wide business worldwide, Johnson & Johnson originated from the production of sterile surgical sutures and auxiliary materials. For more than a century, Johnson & Johnson Medical Technology has always been committed to becoming a world-leading medical technology innovator and bringing far-reaching significance to human health with rich and diverse professional accumulation, mission-significant scientific innovation, and high enthusiasm for human health. Influence, let people all over the world have a healthy and beautiful life. At present, in the fields of surgery, cardiovascular and professional solutions, orthopedics and ophthalmology, Johnson & Johnson Medical Technology continues to innovate and deepen its efforts around the world, striving to solve unmet medical needs, reimagine the future of human health, and allow medical solutions to Smarter, more minimally invasive, more personalized, protect life and light up every beam of hope. In 1994, Johnson & Johnson Medical Technology entered the Chinese market. Currently, Johnson & Johnson Medical Technology has more than 5,000 employees in China, of which 85% are new generation employees. It is headquartered in Shanghai and has offices in Beijing, Guangzhou and other places. On the road of growing together with China's medical and health industry, we will continue to expand and improve our product layout and supply chain production capacity in China. At present, medical technology has become Johnson & Johnson's largest business segment in China. In recent years, Johnson & Johnson Medical Technology has continued to deepen its layout of end-to-end supply chain systems in China, improve local intelligent manufacturing capabilities, introduce global advanced product, technology and quality management experience, and help the industry develop at a high quality and high speed. The integrated supply chain production base located in Suzhou Industrial Park is a large comprehensive industrial park of Johnson & Johnson Medical Technology in China. It integrates the research and development and manufacturing of medical equipment, technological innovation and cooperation, global shared services, regional procurement and supplier management. and other diversified business functions, among which the intelligent manufacturing factory produces a series of innovative products such as surgery and orthopedics, responds to local demand and supplies globally. Johnson & Johnson Medical Technology not only focuses on cultivating and upgrading local intelligent manufacturing capabilities, but also further focuses on local R&D and innovation capabilities. In addition to Suzhou Supply Chain Base, Guangzhou Beixiu Biotechnology Co., Ltd., a wholly-owned subsidiary of Johnson & Johnson, is a biotechnology company specializing in technology development, research and production of pig-derived biological products. Beixiu independently developed the technology to extract fibrinogen and thrombin from mammalian blood, which is the world's first biomedical innovation. On the road to growing together with China's medical and healthcare industry, Johnson & Johnson Medical Technology has deepened the professional education and training of Chinese professional medical staff and is committed to becoming a trustworthy partner of Chinese medical staff. In line with the purpose of "exploring human technology and caring about human health", three Johnson & Johnson Medical Technology Professional Education Academic Centers located in Beijing, Shanghai and Boao Lecheng Medical Pilot Zone and the digital doctor training and education platform "Ling Yimai" provide professional knowledge, Training to adapt to China's medical service environment and innovative medical education forms will be promoted to the professional and systematic development of continuing medical education. In addition, Johnson & Johnson Medical Technology is also actively working with partners from all walks of life to promote innovation cooperation, accelerate the transformation of innovative results, and serve patients. As part of Johnson & Johnson's China Innovation Engine Strategy, Johnson & Johnson cooperates with local companies to leverage digital technologies such as artificial intelligence, surgical robots, and big data to assist doctors in more effective perioperative work and establish localized digital surgical solutions.

Shaanxi YXchuang Biotechnology Co., Ltd

Shaanxi Yingyuan Xingchuang Biotechnology today it has been graduallymove from singleness to high-tech mode enterprise, focusing on production,R&D, Sales andOEM. A large-scale enterprise with 55,000 square meter of modernized new factory buildings andoffice buildings, 35,000 square meter standardized clean room, 100,000 grade cleaned room, and2000 square meter high standard laboratory. Our company offers variety of products which can meet your multifarious demands.including API Powder.Pharmaceutical Intermediates.Vitamins Powder.Plant Extracts.Food Additive.Peptide Powder and so on We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force. Shaanxi Yingyuan Xingchuang Biotechnology Co., LTDhas got ISO9001&ISO14001 certificates. Adhering to the business principle of mutual benefits, we have had a good reputation among our customers because of our perfect services, quality products and competitive prices. We warmly welcome customers from at home and abroad to cooperate with us for common success.

WuXi AppTec Co., Ltd.

WuXi AppTec (stock code: 603259.SH/2359.HK) provides integrated, end-to-end new drug research and development and production services to the global biopharmaceutical industry, and has operating bases in Asia, Europe, North America and other places. WuXi AppTec continuously lowers R&D threshold through its unique "CRDMO" and "CTDMO" business models, helps customers improve R&D efficiency and brings more breakthrough treatment plans to patients. Its service scope covers chemical drug research and development, production, and biology. Research, preclinical testing and clinical trial research and development, cell and gene therapy research and development, testing and production and other fields. In 2022, WuXi AppTec was rated as ESG (Environmental, Social and Governance) AA by MSCI. At present, the company's empowerment platform is carrying R&D and innovative projects from more than 5,950 partners from more than 30 countries around the world, and is committed to bringing more new and good drugs to patients around the world, so as to achieve "making the world without any difficulties" as soon as possible The vision of medicine, difficult to cure diseases.

Kobayashi Pharmaceutical (China) Co., Ltd.

Kobayashi Pharmaceutical (China) Co., Ltd. is a wholly-owned subsidiary of a Japanese listed company [Kobayashi Pharmaceutical Co., Ltd.]. Kobayashi Pharmaceutical Co., Ltd. is a product development company with a history of more than 130 years, mainly engaged in the research, development, production and sales of drugs, medical devices, daily necessities, food, etc. The products are not only sold in Japan, but are also sold to the United States, the United Kingdom, Southeast Asia and other parts of the world. Since its establishment 20 years ago, while providing high-quality and high-value-added products to the majority of Chinese consumers, it has also become an indispensable and important component within the group as an important sales base within the Kobayashi Group. In 2003, the "Guanbaobao" brand stickable disposable heating tablet was produced and sold. The product was widely recognized by consumers as soon as it was launched. The main brands sold by the company in China are: disposable heating sheet series [warm baby], medical anti-heating patch series [bingbao patch], aromatic agent series [xiangjuyuan], disposable cleaning paper series [kli clean】. Thanks to the love of consumers, these brands have grown into well-known domestic brands. The origin of Kobayashi Group is to [listen to consumers], to discover demands that have not been productized in daily life but will feel particularly convenient if there is any, and to convert them into high-quality, high-value-added products. This concept is also fully reflected in the group's corporate image slogan [You think, I do it]. The company and all employees will continue to work together to grow together with the rapid growth of China's economy. In 2023, Kobayashi Pharmaceutical China absorbs and merges Shanghai Kobayashi Daily Chemical.

Renhe (Group) Development Co., Ltd.

Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange. The company's stock code is: 000650. The company's predecessor is Jiujiang Chemical Fiber Co., Ltd., which was approved by the Jiangxi Provincial People's Government in 1996. On November 18, 1996 , a company officially listed on the Shenzhen Stock Exchange with the approval of the China Securities Regulatory Commission’s Securities Regulatory Commission (1996) No. 318. In 2006, the company implemented a major asset restructuring, divested its original chemical fiber-related assets, and injected pharmaceutical assets. Through multiple share allocations, transfers, targeted share issuances, etc., the company has become Jiangxi Renhe Pharmaceutical Co., Ltd. and Jiangxi Renhe. China Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Co., Ltd., Jiangxi Heli Pharmaceutical Co., Ltd., Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd., Jiangxi Pharmaceutical Durenhe Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., Jiangxi Shining Pharmaceutical Modern pharmaceutical production and operation enterprises of many subsidiaries such as Jiangxi Ji'an Sanli Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Products Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical City Zhangshu Pharmaceutical Co., Ltd. and other subsidiaries. The company's main business: production and sales of traditional Chinese and Western medicines, raw materials and health-related products, including oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, liniments, suppositories, ointments and other dosage-form drugs, as well as Health-related products. The company's main products: Renhe Kelik, Youkadan series, Fuyanjie series, Dahuolou capsules, Shining eye drops, Qinghuo capsules, Zhengwei capsules, etc. Business scope is: Chinese medicinal materials planting; medicinal seedling cultivation; carton production and sales; computer software development; design, production, release, and agency of various domestic advertisements; building materials, machinery and equipment, hardware and electrical and electronic products, chemical products, Wholesale and retail of metal materials, cultural and sports office supplies, department stores. (Except for the above projects that have special provisions in the country). The company has established and consolidated a sales network covering 30 provinces, cities and autonomous regions across the country. The company adheres to the purpose of "serving human health", follows the corporate philosophy of "people-oriented and harmony-oriented", and the business philosophy of "benevolence and harmony, and win-win" and promotes the corporate spirit of "integrity and unity and keeping pace with the times". With the historical expectation of revitalizing the country's medical industry, we will go to the world and the future with new horizons and new ideas.

Xi'an Gawen Biotechnology Co., Ltd

AHUALYN is specialized in bio-chemical raw materials. we focus on the research, development, production and sales of Cosmetic Ingredients, Health Ingredients, Carbomer, Vitamin, Food Additives, API (Active Pharmaceutical Ingredients) etc. The company established its own independent R & D team, and with the local colleges and universities and research institutions have close relations of cooperationIn strict accordance with the GMP standard requirements of production safety. Force in the pursuit of providing customers with reliable quality of innovative products and services.To the rapid development of new products, stable product quality and high technology sustained and stable technical support to win the global customer recognition, the company's products are exported to the United States, Europe, Asia, Australia, Africa and other countries. We strictly monitors product quality, pursues excellence in products, and takes the concept of high quality, honest management, and customer first. The principle is to provide our customers with quality services.

Guilin Sanjin Pharmaceutical Co., Ltd.

Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin Group. It mainly engages in the research and development and production of traditional Chinese medicine and natural medicines. It is one of the earliest manufacturers in China to produce modern Chinese medicine preparations. Since 1985, Guilin Sanjin has insisted on reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a nationally renowned modern traditional Chinese medicine enterprise. As a well-known high-tech enterprise inside and outside the district, Sanjin has established innovative platforms such as nationally recognized enterprise technology centers, postdoctoral research workstations and Guangxi Institute of Traditional Chinese Medicine Industrialization Engineering. Over the years, we have been committed to promoting and implementing the modernization plan of the traditional Chinese medicine industry and actively cultivating and improving the independent innovation capabilities of enterprises. The company's new special Chinese medicines are all developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and has 42 special varieties independently developed by Guilin Watermelon Cream, Watermelon Cream Throat Soft Tablets, Sanjin Tablets, Naomaitai Capsules, etc. After years of hard work, Sanjin has formed strong professional and market advantages in throat, oral medication and urinary system medication. Its representative products, Sanjin Watermelon Cream Series and Sanjin Tablets, have been at the forefront of similar Chinese patent medicines in the country for many years. In July 2009, Guilin Sanjin successfully entered the capital market with a new look of high growth and high efficiency, and ushered in a new stage of rapid development of the enterprise. In recent years, in order to actively respond to the call of Guilin Municipal Party Committee and Municipal Government to "develop westward and create a new Guilin", and to resolve the contradiction between the dispersed production bases and warehousing facilities of enterprises and the rapid development of enterprises, Sanjin has launched the "Sanjin". The construction of the modern traditional Chinese medicine industrialization technology transformation project. At present, the first phase of the project has been officially put into production and the overall relocation of the main production lines has been achieved. Facing the future, Sanjin will uphold the corporate mission of "innovation to promote pharmaceutical progress" and the corporate spirit of "dare to be the first", implement the "one body and two wings" development strategy with traditional Chinese medicine as the main body and committed to developing biopharmaceuticals and the big health industry, Quality and reputation are the first life of the enterprise, breakthroughs and innovation, continuously enhances the competitive strength of Sanjin, and is enterprising, with the goal of developing to serve the country and repay investors, and with the goal of building China's advanced pharmaceutical manufacturing group, we will promote the modernization and internationalization of the traditional Chinese medicine industry!

Jiangsu Yabang Pharmaceutical Group Co., Ltd.

Jiangsu Yabang Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Changzhou City, Jiangsu Province. It is a large comprehensive pharmaceutical group integrating new drug research and development, raw material production, pharmaceutical preparation production and pharmaceutical circulation. The current employees are more than 2,000 and the total assets are more than 1 billion yuan. At present, the group is centered on Jiangsu Yabang Pharmaceutical Group Co., Ltd., and owns Yabang Pharmaceutical Co., Ltd., Jiangsu Yabang Johnson Pharmaceutical Co., Ltd., Jiangsu Yabang Epson Pharmaceutical Co., Ltd., and Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd. 6 wholly-owned subsidiaries including Co., Ltd., Changzhou Yabang Pharmaceutical Co., Ltd., Changzhou Yabang Pharmaceutical Research Institute Co., Ltd. After years of scientific research and innovation, Yabang Pharmaceutical has now formed a high-tech specialty covering anti-infective drugs, cardiovascular and cerebrovascular drugs, respiratory and immune system drugs, and has 7 major series, nearly 20 dosage forms, and more than 200 specifications. Product group. A marketing network covering 29 provinces (cities), 40 regions and more than 1,000 marketers across the country has been established.

Tianjin Shining Deal Co., Ltd

Tianjin Shining Deal Co., Ltd has more than 20 years of experiences in international export and import business. We started as a chemical products company named BRG Products Co., Ltd in 2007. And in 2019, Tianjin Shining Deal was established, dedicating in the human health chemicals and equipments with our own brand"ERA Medicals". Our company is located in Tianjin, near Beijing, only 2-3 hours by car to Tianjin Port, which grants us huge convenience for shipping. We have rich experience in sea and air transportation, and we believe that we will provide you with good shipping services. Now our business scopes mainly involve medical consumables, pharmaceutical excipients and other daily chemicals. The main markets include North America, South America, South East Asia, Africa, Middle East and some countries in Europe. We understand the requirements of our customers. We believe that a good reputation, high-quality service and keeping up with market demand will help us go further and more firmly.

Shenzhen Neptunus Group Co., Ltd.

Haiwang Group was founded in Shenzhen in 1989. For more than 30 years, the company has focused on the innovative development of the pharmaceutical and health industry, serving the national strategy, serving the health of the whole people, serving the health of the people wholeheartedly, and continuously promoting the innovation-driven development strategy, becoming the industrial chain of China's pharmaceutical and health industry. A large backbone enterprise with relatively complete, strong independent innovation capabilities and outstanding business model innovation capabilities have two listed companies. Guided by the "Healthy China" strategy, the entire pharmaceutical and health industry chain as the foundation, deploy innovation chains around the industrial chain, layout industrial chains around the innovation chain, promote industrial innovation, and build a new health industry ecosystem; to discover and solve people's health pain points As a starting point, we will strive to provide the people with all-round and full-cycle health services. Comprehensive advantages of the entire industrial chain - Aquaman Group relies on the strong resources accumulated in the development of the pharmaceutical and health industry for more than 30 years to create a comprehensive advantage of the entire pharmaceutical and health industry chain. Based on independent innovation, core business segments such as Neptune Bio, Neptune Star, and Neptune Youpin are integrated with each other and complement each other's advantages to create an industrial matrix for the coordinated development of pharmaceutical industry, pharmaceutical commerce, chain retail, health products and Internet medicine. Outstanding innovation capabilities - Aquaman Group has an advanced domestic independent innovation system for pharmaceutical products. It has R&D platforms such as the National Enterprise Technology Center, the National High-Tech Research and Development Plan Results Industrialization Base, the Academician Workstation, and the Postdoctoral Research Workstation. New drug research and development has achieved fruitful results in the fields of anti-tumor, cardiovascular and cerebrovascular, marine drugs, etc., and has achieved major breakthroughs in the research and development of Class I new drugs. The pharmaceutical business network and chain pharmacies spread all over the country - Aquaman Pharmaceutical Business Network is located in more than 20 provinces and cities across the country. Neptune Star pharmacies are distributed in more than 70 large and medium-sized cities across the country, with more than 4,000 direct stores and annual sales exceeding 10 billion. National large-scale health products production and sales system - Haiwang Youpin has 106 registered health food approval documents and 221 registered health food approval documents; 5 large health food production bases, with annual production capacity expected to reach 10 billion yuan, covering the mainstream market The product dosage form has strong production capacity and production and supporting service capabilities. We have accumulated rich resources and experience in product research and development, production, marketing, promotion, consumer education, etc. Aquaman actively promotes the "Aquaman Excellent Products" strategy, is committed to building an efficient health care product operation system, is committed to allowing every Chinese to enjoy nutritional health care, and is committed to creating a price depression for all healthy and nutritious products, so that reasonable value of nutritional health can become The equal power of everyone provides scientific nutrition to hundreds of millions of Chinese people and helps the steady progress of "Healthy China".